dsp 4 has been researched along with nisoxetine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunswick, DJ; Frazer, A; Tejani-Butt, SM | 1 |
| Harkin, A; Nowak, G; Paul, IA | 1 |
| Eriksson, KS; Wisor, JP | 1 |
3 other study(ies) available for dsp 4 and nisoxetine
| Article | Year |
|---|---|
[3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.
Topics: Animals; Benzylamines; Cerebral Cortex; Fluoxetine; Male; Norepinephrine; Premedication; Radioligand Assay; Rats; Rats, Inbred Strains | 1990 |
Noradrenergic lesion antagonizes desipramine-induced adaptation of NMDA receptors.
Topics: Adaptation, Physiological; Animals; Antidepressive Agents, Tricyclic; Benzylamines; Cerebral Cortex; Desipramine; Fluoxetine; Glycine; Kynurenic Acid; Male; Mice; Norepinephrine; Receptors, N-Methyl-D-Aspartate | 2000 |
Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil.
Topics: Adrenergic Agents; Animals; Benzhydryl Compounds; Benzylamines; Brain; Central Nervous System Stimulants; Dopamine; Dopamine Agonists; Fluoxetine; Male; Mice; Modafinil; Narcolepsy; Neural Pathways; Norepinephrine; Quinpirole; Sleep; Wakefulness | 2005 |